Literature DB >> 2355728

[Pharmacokinetics of bismuth preparations in patients with gastritis and ulcer disease].

R Raedsch1, I Walter-Sack, E Weber, J Blessing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2355728     DOI： 10.1007/bf01648907

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  3 in total

1.  The safety profile of De-Nol.

Authors:  J P Bader
Journal:  Digestion       Date:  1987       Impact factor: 3.216

2.  The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate.

Authors:  C U Nwokolo; C J Gavey; J T Smith; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1989-02       Impact factor: 8.171

3.  Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.

Authors:  C J Gavey; M L Szeto; C U Nwokolo; J Sercombe; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1989-02       Impact factor: 8.171
  3 in total
  2 in total

1.  Bioavailability of bismuth from 205Bi-labelled pharmaceutical oral Bi-preparations in rats.

Authors:  B Dresow; P Nielsen; R Fischer; J Wendel; E E Gabbe; H C Heinrich
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.

Authors:  Jose M Brum; Roger D Gibb; David L Ramsey; Guhan Balan; Bruce R Yacyshyn
Journal:  Dig Dis Sci       Date:  2020-08-08       Impact factor: 3.199
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.